EV3 Technologies Ltd, founded by NHS Clinical Entrepreneur Aizemea Okojie, is at the forefront of developing an innovative solution to support women with pelvic organ prolapse (POP).
The company’s mission is to create a next-generation medical device that not only improves patient outcomes but also enhances comfort and provides a more effective non-surgical management option.
EV3 Technologies Ltd has been awarded an Innovate UK Smart Grant of £478,000. This substantial funding will be instrumental in supporting the development and validation of its prototype. The grant will facilitate advancements in engineering design, engagement with end users for iterative feedback, and preparation for future clinical trials. Ultimately, this funding will accelerate the innovation’s pathway toward regulatory approval.
Aizemea Okojie, Founder of EV3 Technologies Ltd, said; “This funding from Innovate UK is a game-changer for EV3 Technologies Ltd. It enables us to take a significant step forward in developing an innovative, patient-centred solution for pelvic organ prolapse. With the support of Health Innovation Wessex (HIN Wessex) and the NHS Clinical Entrepreneur Programme, we are committed to delivering a product that improves quality of life for women while reducing the burden on healthcare systems.”
About Pelvic Organ Prolapse (POP)
Pelvic organ prolapse is a condition where the pelvic organs, such as the bladder, uterus, or rectum, descend into or outside of the vaginal canal due to weakened pelvic floor muscles. This condition can cause significant discomfort and impact the quality of life for many women. Traditional treatment options include surgical interventions, which can be invasive and carry risks. Non-surgical options, such as pessaries, are available but may not be suitable for all patients.
The Role of Innovate UK Smart Grants
Innovate UK Smart Grants are designed to support the most innovative and game-changing ideas across various sectors. These grants aim to drive economic growth and improve the quality of life by funding projects that have the potential for significant impact. The grants are highly competitive and are awarded to projects that demonstrate strong potential for commercial success and societal benefit.
Support from Health Innovation Wessex and NHS Clinical Entrepreneur Programme
Health Innovation Wessex (HIN Wessex) and the NHS Clinical Entrepreneur Programme provide crucial support to innovators in the healthcare sector. HIN Wessex focuses on accelerating the adoption of high-impact innovations within the NHS, ensuring that new technologies meet clinical needs and improve patient care. The NHS Clinical Entrepreneur Programme, the largest of its kind, supports NHS staff in developing and scaling their innovative ideas without leaving the health service
With the combined support of these organisations, EV3 Technologies Ltd aims to bring its groundbreaking solution for pelvic organ prolapse to market, ultimately benefiting countless women and the healthcare system as a whole.
For more information on the project please contact Aizemea Okojie on LinkedIn